To the central content area
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6446 PEC
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chingleou Teng Jack Hwang Ko-Chung Lin 02-26557688 13F, No.3, YuanQu St., NanKang Dist.,Taipei 115, Taiwan 2016/07/19
Industry Main Business
Biotechnology and Medical Care PharmaEssentia was founded in 2003 by a group of Taiwanese-American Executives and high-ranking scientists coming from leading biotech and pharmaceutical companies in the US. PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human disease. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life, with a goal to be the first biotech company that discover, develop, and manufacture new drugs in Taiwan, aiming for market in Europe and US.
Market Information ( 2021/10/27 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
177.493 97.80  96.90  97.30  0.40  140 0.06 N/A N/A
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
變更交易 Y N N N N Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.